308 related articles for article (PubMed ID: 35890078)
1. Novel Therapies to Address Unmet Needs in ITP.
Mingot-Castellano ME; Bastida JM; Caballero-Navarro G; Entrena Ureña L; González-López TJ; González-Porras JR; Butta N; Canaro M; Jiménez-Bárcenas R; Gómez Del Castillo Solano MDC; Sánchez-González B; Pascual-Izquierdo C; On Behalf Of The Gepti
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890078
[TBL] [Abstract][Full Text] [Related]
2. Advances in Diagnosis and Treatments for Immune Thrombocytopenia.
Nomura S
Clin Med Insights Blood Disord; 2016; 9():15-22. PubMed ID: 27441004
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
Nugent D; McMillan R; Nichol JL; Slichter SJ
Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
[TBL] [Abstract][Full Text] [Related]
4. Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice.
Song F; Al-Samkari H
J Blood Med; 2021; 12():653-664. PubMed ID: 34345191
[TBL] [Abstract][Full Text] [Related]
5. New treatments for primary immune thrombocytopenia.
Mingot-Castellano ME
Blood Coagul Fibrinolysis; 2022 Jan; 33(Suppl 1):S8-S11. PubMed ID: 34654012
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenia.
Bussel J; Cooper N; Boccia R; Zaja F; Newland A
Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP).
Zufferey A; Kapur R; Semple JW
J Clin Med; 2017 Feb; 6(2):. PubMed ID: 28208757
[TBL] [Abstract][Full Text] [Related]
9. Immune Thrombocytopenia (ITP): Current Limitations in Patient Management.
Terrell DR; Neunert CE; Cooper N; Heitink-Pollé KM; Kruse C; Imbach P; Kühne T; Ghanima W
Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33266286
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and management of primary immune thrombocytopenia.
Kashiwagi H; Tomiyama Y
Int J Hematol; 2013 Jul; 98(1):24-33. PubMed ID: 23702914
[TBL] [Abstract][Full Text] [Related]
11. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
12. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
[TBL] [Abstract][Full Text] [Related]
14. Efgartigimod alfa for the treatment of primary immune thrombocytopenia.
Broome C
Ther Adv Hematol; 2023; 14():20406207231172831. PubMed ID: 37188068
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
16. New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia.
Althaus K; Faul C; Bakchoul T
Hamostaseologie; 2021 Aug; 41(4):275-282. PubMed ID: 33348391
[TBL] [Abstract][Full Text] [Related]
17. Emerging Therapies in Immune Thrombocytopenia.
Audia S; Bonnotte B
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801294
[TBL] [Abstract][Full Text] [Related]
18. Romiplostim as a treatment for immune thrombocytopenia: a review.
Chalmers S; Tarantino MD
J Blood Med; 2015; 6():37-44. PubMed ID: 25632241
[TBL] [Abstract][Full Text] [Related]
19. Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia.
Perdomo J
Immunotargets Ther; 2016; 5():1-7. PubMed ID: 27529057
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in treatments of adult immune thrombocytopenia.
Kim DS
Blood Res; 2022 Apr; 57(S1):112-119. PubMed ID: 35483935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
